Citadel Advisors’s Healthcare Services Acquisition Corporation Warrant HCARW Stock Holding History

Citadel Advisors’s Portfolio HCARW Stock Details HCARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-602,061	Closed	-$18K	–	15823
2022 Q3	$18K	Buy	602,061 +2,061	+0.3%	+$120	﹤0.01%	12124
2022 Q2	$60K	Sell	600,000 -150,100	-20%	-$26.5K	﹤0.01%	11818
2022 Q1	$262K	Buy	750,100 +100	+0%	+$43	﹤0.01%	10904
2021 Q4	$390K	Sell	750,000 -148,331	-17%	-$95.1K	﹤0.01%	10287
2021 Q3	$593K	Buy	898,331 +148,188	+20%	+$105K	﹤0.01%	9449
2021 Q2	$667K	Buy	750,143 +450,143	+150%	+$328K	﹤0.01%	9361
2021 Q1	$186K	Buy	+300,000	New	+$369K	﹤0.01%	11791

Citadel Advisors's HCARW Position: Q4 2022 in Review

Citadel Advisors sold out of Healthcare Services Acquisition Corporation Warrant (HCARW) in Q4 2022, closing a stake of 602,061 shares — an estimated $18K sold.

Citadel Advisors first reported a position in HCARW in Q1 2021 and held it in 7 quarters. The position peaked at $667K in Q2 2021. 0 funds tracked by Wall St. Rank hold HCARW as of Q4 2022.

Citadel Advisors reported no remaining Healthcare Services Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
Citadel Advisors sold 602,061 Healthcare Services Acquisition Corporation Warrant shares in Q4 2022, an estimated $18K.
Citadel Advisors first reported a position in Healthcare Services Acquisition Corporation Warrant in Q1 2021 and held it in 7 quarters.
Citadel Advisors's Healthcare Services Acquisition Corporation Warrant position peaked at $667K in Q2 2021.
0 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Warrant as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.